These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21504185)

  • 21. Effects of metal binding on solubility and resistance of physiological prions depend on tissues and glycotypes.
    Kuczius T; Kelsch R
    J Cell Biochem; 2013 Dec; 114(12):2690-8. PubMed ID: 23794222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane interactions and conformational preferences of human and avian prion N-terminal tandem repeats: the role of copper(II) ions, pH, and membrane mimicking environments.
    Di Natale G; Pappalardo G; Milardi D; Sciacca MF; Attanasio F; La Mendola D; Rizzarelli E
    J Phys Chem B; 2010 Nov; 114(43):13830-8. PubMed ID: 20936829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prion paradox: infection or polymerisation?
    Biro JC
    Appl Bioinformatics; 2003; 2(3 Suppl):S25-30. PubMed ID: 15130813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calnexin inhibits thermal aggregation and neurotoxicity of prion protein.
    Wang W; Chen R; Luo K; Wu D; Huang L; Huang T; Xiao G
    J Cell Biochem; 2010 Oct; 111(2):343-9. PubMed ID: 20506117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular modelling indicates that the pathological conformations of prion proteins might be beta-helical.
    Downing DT; Lazo ND
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):453-60. PubMed ID: 10510313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PrPSc-like prion protein peptide inhibits the function of cellular prion protein.
    Brown DR
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):511-8. PubMed ID: 11085945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clustered negative charges on the lipid membrane surface induce beta-sheet formation of prion protein fragment 106-126.
    Miura T; Yoda M; Takaku N; Hirose T; Takeuchi H
    Biochemistry; 2007 Oct; 46(41):11589-97. PubMed ID: 17887730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation.
    Nicholson EM; Mo H; Prusiner SB; Cohen FE; Marqusee S
    J Mol Biol; 2002 Feb; 316(3):807-15. PubMed ID: 11866533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
    Uppington KM; Brown DR
    J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
    Gilch S; Nunziante M; Ertmer A; Schätzl HM
    Vet Microbiol; 2007 Aug; 123(4):377-86. PubMed ID: 17493775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
    Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
    Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
    J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards cellular receptors for prions.
    Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
    Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
    White AR; Guirguis R; Brazier MW; Jobling MF; Hill AF; Beyreuther K; Barrow CJ; Masters CL; Collins SJ; Cappai R
    Neurobiol Dis; 2001 Apr; 8(2):299-316. PubMed ID: 11300725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
    Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
    J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linkage isomerism in the binding of pentapeptide Ac-His(Ala)3His-NH2 to (ethylenediamine)palladium(II): effect of the binding mode on peptide conformation.
    Hoang HN; Bryant GK; Kelso MJ; Beyer RL; Appleton TG; Fairlie DP
    Inorg Chem; 2008 Oct; 47(20):9439-49. PubMed ID: 18788796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.